Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis TruePrime WGA Kit

Sygnis has launched the TruePrime WGA kit for whole-genome amplification of entire genomes from various sample types.

The TruePrime technology is based on multiple displacement amplification (MDA) of DNA or RNA species from a variety of samples. TruePrime combines Sygnis' recently discovered DNA primase TthPrimPol with its Phi29 polymerase, and does not require the use of any synthetic random primers. The new kit eliminates common artifacts linked to the use of oligonucleotides, reduces amplification bias, is insensitive to external DNA contaminations, and has a high reproducibility, the company said. These features make it attractive for researchers who are working with limited sample volumes but do not need to obtain DNA from individual cells, Sygnis added.

The TruePrime WGA kit is available globally through distributors as well as through Sygnis' TruePrime online shop. It is available in 25- or 100-reaction formats.

Sygnis also previously launched a TruePrime kit for amplification of DNA from single cells.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.